Literature DB >> 27359082

Prenatal detection of major congenital heart disease - optimising resources to improve outcomes.

Siobhan Corcoran1, Kaleigh Briggs2, Hugh O' Connor3, Sieglinde Mullers3, Cathy Monteith3, Jennifer Donnelly4, Patrick Dicker2, Orla Franklin5, Fergal D Malone3, Fionnuala M Breathnach3.   

Abstract

INTRODUCTION: Congenital heart disease (CHD) is the most common major structural fetal abnormality and the benefits of prenatal detection are well described. The objective of this study was to evaluate the precision of prenatal diagnosis at a single tertiary referral unit over two three year periods (2006, 2007, 2008 and 2010, 2011, 2012), before and after a prenatal screening protocol for CHD was developed to include extended cardiac views, mandatory recall for suboptimal views, and a multidisciplinary Fetal Cardiac clinic was established. There exists a single national centre for paediatric cardiothoracic surgery in Ireland, a situation which facilitates near complete case ascertainment.
MATERIALS AND METHODS: Surgery records of the National Children's Cardiac Centre were interrogated for all cases of major congenital heart defects requiring surgical intervention in the first six months of life. Minor procedures such as ligation of a patent ductus arteriosus and isolated atrial septal defect repairs were excluded. Analyses of the Fetal Medicine database at the Rotunda Hospital (a stand-alone tertiary level perinatology centre with 8500 deliveries per year) and the mortality data at the Perinatal Pathology department were conducted. The Cochrane-Armitage trend test was used to determine statistical significance in prenatal detection rates over time.
RESULTS: 51,822 women delivered during the study period, and the incidence of major congenital heart disease either that underwent surgical intervention or that resulted in perinatal mortality, was 238/51,822 (0.5%). Prenatal detection of major CHD increased from 31% to 91% (p<0.001). Detection of critical duct-dependant lesions rose from 19% to 100%.
CONCLUSION: We attribute the dramatic improvement in prenatal detection rates to the multifaceted changes introduced during the study period. Improved prenatal detection for births that are geographically remote from the National Paediatric Cardiac Centre will require local replication of this prenatal programme.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Congenital heart disease; Duct dependant lesions; Prenatal detection; Screening

Mesh:

Year:  2016        PMID: 27359082     DOI: 10.1016/j.ejogrb.2016.06.008

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  4 in total

1.  Resource Utilization for Prenatally Diagnosed Single-Ventricle Cardiac Defects: A Philadelphia Fetus-to-Fontan Cohort Study.

Authors:  Benjamin Zielonka; Brian S Snarr; Michael Y Liu; Xuemei Zhang; Christopher E Mascio; Stephanie Fuller; J William Gaynor; Thomas L Spray; Jack Rychik
Journal:  J Am Heart Assoc       Date:  2019-05-29       Impact factor: 5.501

2.  Prenatal diagnosis and prevalence of critical congenital heart defects: an international retrospective cohort study.

Authors:  Marian K Bakker; Jorieke E H Bergman; Sergey Krikov; Emmanuelle Amar; Guido Cocchi; Janet Cragan; Hermien E K de Walle; Miriam Gatt; Boris Groisman; Shiliang Liu; Wendy N Nembhard; Anna Pierini; Anke Rissmann; Shanthi Chidambarathanu; Antonin Sipek; Elena Szabova; Giovanna Tagliabue; David Tucker; Pierpaolo Mastroiacovo; Lorenzo D Botto
Journal:  BMJ Open       Date:  2019-07-02       Impact factor: 2.692

Review 3.  Recent developments have made female permanent contraception an increasingly attractive option, and pregnant women in particular ought to be counselled about it.

Authors:  Douwe A A Verkuyl
Journal:  Contracept Reprod Med       Date:  2016-12-12

4.  Longitudinal Assessment of Outcome From Prenatal Diagnosis Through Fontan Operation for Over 500 Fetuses With Single Ventricle-Type Congenital Heart Disease: The Philadelphia Fetus-to-Fontan Cohort Study.

Authors:  Michael Y Liu; Benjamin Zielonka; Brian S Snarr; Xuemei Zhang; J William Gaynor; Jack Rychik
Journal:  J Am Heart Assoc       Date:  2018-10-02       Impact factor: 5.501

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.